| Entry |
|
|---|
| Name |
Tositumomab 131 iodine;
Tositumomab iodine 131I;
Bexxar (TN) |
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Immunomodulator, Anti-CD20 antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
V VARIOUS
V10 THERAPEUTIC RADIOPHARMACEUTICALS
V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALS
V10XA Iodine (131I) compounds
V10XA53 Tositumomab/iodine (131I) tositumomab
D08622 Tositumomab 131 iodine
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Other cell surface molecules
CD molecules
CD20
D08622 Tositumomab 131 iodine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
